Study of Iopofosine I-131 (CLR 131) in Select B-Cell Malignancies (CLOVER-1) With Expansion in Waldenstrom
Clinical trial NCT02952508 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02952508
- Sponsor
- Cellectar Biosciences, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-26
- Primary completion
- 2026-06-22
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.